Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Smit

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2009
[Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]S Y El Sharouni, J G J V Aerts, S Senan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: a randomized, controlled trialA M H Krebber, F Jansen, B I Witte, et al.
Cancer Treatment Reviews|October 5, 2023
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatmentsFenneke Zwierenga, Bianca A M H van Veggel, Anke van den Berg, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2020
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy RegistryH J M Smit, J Aerts, M van den Heuvel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2026
Erratum to 'Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis': [Annals of Oncology. Volume 36, Issue 11, November 2025, Pages 1389-1399]H S Rugo, E Tokunaga, H Iwata, et al.
Lung Cancer (Amsterdam, Netherlands)|January 26, 2010
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studiesV Surmont, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†A-M C Dingemans, H J M Groen, G J M Herder, et al.
Thorax|January 26, 2002
Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitalsG J M Herder, P Verboom, E F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Molecular Tumor Boards: current practice and future needsD L van der Velden, C M L van Herpen, H W M van Laarhoven, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancerB van Veggel, J F Vilacha Madeira R Santos, S M S Hashemi, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2009
[Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]S Y El Sharouni, J G J V Aerts, S Senan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: a randomized, controlled trialA M H Krebber, F Jansen, B I Witte, et al.
Cancer Treatment Reviews|October 5, 2023
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatmentsFenneke Zwierenga, Bianca A M H van Veggel, Anke van den Berg, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2020
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy RegistryH J M Smit, J Aerts, M van den Heuvel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2026
Erratum to 'Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis': [Annals of Oncology. Volume 36, Issue 11, November 2025, Pages 1389-1399]H S Rugo, E Tokunaga, H Iwata, et al.
Lung Cancer (Amsterdam, Netherlands)|January 26, 2010
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studiesV Surmont, E F Smit, M de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†A-M C Dingemans, H J M Groen, G J M Herder, et al.
Thorax|January 26, 2002
Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitalsG J M Herder, P Verboom, E F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Molecular Tumor Boards: current practice and future needsD L van der Velden, C M L van Herpen, H W M van Laarhoven, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancerB van Veggel, J F Vilacha Madeira R Santos, S M S Hashemi, et al.
Pageof 19